Clinical Outcomes of Ileostomy Closure before Adjuvant Chemotherapy after Rectal Cancer Surgery: An Observational Study from a Chinese Center
Table 1
Demographics and clinicopathologic characteristics of the study groups.
Group I ()
Group II ()
Group III ()
value
Sex
Male
16 (66.7%)
41 (77.4%)
32 (58.2%)
0.104
Female
8 (33.3%)
12 (22.6%)
23 (41.18%)
Age (years)
0.304
BMI (kg/m2)
0.073
Comorbidity
Cardiovascular diseases
2 (8.3%)
8 (15.1%)
12 (21.8%)
0.310
Diabetes
0 (0.0%)
6 (4.5%)
3 (2.3%)
0.165
Pulmonary diseases
1 (4.2%)
1 (1.9%)
1 (1.8%)
0.789
Renal diseases
0 (0.0%)
1 (1.9%)
2 (3.6%)
0.590
ASA class
0.961
I
3 (12.5%)
5 (9.4%)
4 (7.3%)
II
19 (79.2%)
44 (83.0%)
47 (85.5%)
III
2 (8.3%)
4 (7.5%)
4 (7.3%)
Type of surgery
0.994
Laparoscopic
23 (95.8%)
51 (96.2%)
53 (96.4%)
Conversion to open
1 (4.2%)
2 (3.8%)
2 (3.6%)
cTNM stage
0.706
I
1 (4.2%)
5 (5.7%)
18 (7.3%)
II
5 (20.8%)
17 (32.1%)
33 (21.8%)
III
18 (75.0%)
33 (62.3%)
39 (70.9%)
ypTNM stage
0.471
0
1 (4.2%)
0 (0.0%)
1 (1.8%)
I
2 (8.3%)
4 (7.5%)
9 (16.4%)
II
12 (50.0%)
25 (47.2%)
28 (50.9%)
III
9 (37.5%)
24 (45.3%)
17 (30.9%)
Neoadjuvant CRT
10 (41.7%)
19 (35.8%)
25 (45.5%)
0.595
Tumor location (cm)
0.698
3-5
9 (37.5%)
22 (41.5%)
16 (29.1%)
0.597
6-10
9 (37.5%)
23 (43.4%)
27 (49.1%)
11-15
6 (25.0%)
8 (15.1%)
12 (21.8%)
Values are presented as the or number of patients (%). Measured before ileostomy closure. Pathological stage according to UICC. Tumor lower border from the anal verge. BMI: body mass index; ASA: American Society of Anesthesiologists; UICC: Union Internationale Contre le Cancer; CRT: chemoradiotherapy.
